Senate backs bipartisan bill to speed drugs and avert shortages
The Senate passed a major bipartisan bill on Thursday to prevent drug shortages and to speed federal approval of lifesaving medicines, including lower-cost generic versions of biotechnology products. A similar bill is on a fast track to approval in the House. President Obama, consumer groups and pharmaceutical companies strongly support the legislation. The measures reflect the government's effort to keep up with new therapies developed during a decade of rapid progress in biomedical research.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- IOM Identifies GME Problems, Calls for Finance Changes
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- Anatomy of 3 Health System Rebranding Efforts